Schillaci and Roccella developing new guidelines for triptorelin in managing dysphoria

The Ministry of Health and the Ministry of Family are working together to address the issue of gender dysphoria in minors, particularly focusing on the use of triptorelin, a puberty-blocking drug. This effort is being led by Ministers Orazio Schillaci and Eugenia Roccella, who are bringing together a team of technicians and experts to develop new guidelines based on scientific literature and experiences from other countries.

The joint statement from the two ministries announced this initiative and highlighted the work that has been done so far to address gender dysphoria and the use of blockers. The statement mentions the involvement of scientific societies, the National Bioethics Committee, and a survey conducted in various regions regarding the clinical and financial aspects of prescribing triptorelin.

This collaborative effort aims to reexamine the issue of using triptorelin in cases of gender dysphoria in minors and establish clear guidelines for its use in the future. The composition of the expert panel will be finalized in the coming days to further advance this important discussion.

By Samantha Johnson

As a content writer at, I craft engaging and informative articles that aim to captivate readers and provide them with valuable insights. With a background in journalism and a passion for storytelling, I thoroughly enjoy delving into diverse topics, conducting research, and producing compelling content that resonates with our audience. From breaking news pieces to in-depth features, I strive to deliver content that is both accurate and engaging, constantly seeking to bring fresh perspectives to our readers. Collaborating with a talented team of editors and journalists, I am committed to maintaining the high standards of journalism upheld by our publication.

Leave a Reply